U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT06798675) titled 'Phase 2a Study for PK/PD of NC-001' on Jan. 07.
Brief Summary: CHRONIC EUVOLEMIC HYPONATREMIA
Study Start Date: March, 2025
Study Type: INTERVENTIONAL
Condition:
CHRONIC HYPONATREMIA
Intervention:
DRUG: nC-001
solid dosage form single dose
DRUG: Placebo
Placebo
Recruitment Status: NOT_YET_RECRUITING
Sponsor: nephCentric
Published by HT Digital Content Services with permission from Health Daily Digest....